Bile duct cancers can be notoriously difficult to diagnose as obtaining tissue for diagnosis is sometimes very difficult and very often tests may need to be repeated many times. Most bile duct cancers are diagnosed after a series of tests. These include:
-
Blood tests: to assess the level of jaundice, liver functions, tumour markers etc.
-
CT scan of the abdomen: a triphasic scan of the abdomen is usually done to detect the exact location of the cancerous mass and determine its extent and relation to adjacent structures such as the liver and blood vessels. Especially in intrahepatic cholangiocarcinomas, certain typical features of the tumour on this scan help greatly in the diagnosis.
-
ERCP and cholangioscopy: Endoscopic examination of the bile duct through the ampulla is usually required both for diagnosis of cancer (through cytology) as well as to relieve jaundice by inserting a plastic or metallic stent.
-
Magnetic Resonance Cholangiopancreatography (MRCP): is a non-invasive technique using MRI to delineate the biliary tree and determine the location and extent of the tumour.
-
PET-CT: Used to determine if there is any focus of the spread of the tumour from the biliary tree to any other part of the body.
-
Biopsy: CT guided or Endoscopic ultrasound-guided biopsy or cytology is used to confirm the pathological diagnosis in most bile duct cancers. These may sometimes need to be repeated multiple times before a positive result is obtained. Occasionally a spy-glass cholangioscopy and brushings from the bile ducts may be required.